Buy on Value: Laureate's Recovery Looks Real and Underpriced

Laureate Education operates higher-education institutions primarily in Mexico and Peru. The company runs both on-campus and digital programs to deliver undergraduate and graduate degrees. For investors, the important fundamentals are: enrollment momentum, margin conversion as programs digitalize, free cash flow generation and capital return policy. Laureate is delivering on several of these axes: it reported strong revenue growth in recent quarters, raised guidance, and has been repurchasing stock.

Concrete evidence behind the thesis

• Revenue momentum: the company reported Q2 2025 revenue of $524.2M, a 5% year-over-year increase that beat estimates (reported 08/01/2025).
• Guidance lift: management raised full-year guidance to roughly $1.686B in revenue, a sign that enrollment and price/mix improvements are working (reported 02/13/2026).
• Free cash flow: trailing free cash flow is sizeable at $263.1M, giving the company firepower to invest and buy back stock.
• Balance sheet: debt-to-equity is very low at 0.11, and cash as a ratio of assets sits around 0.31 on the reported metrics—this is not a leverage story; it is an operational and cash-flow story.
• Valuation anchors: the equity trades at a P/E of ~18.4 and EV/EBITDA of ~9.8, while price-to-sales is ~2.92. For a company generating consistent FCF and returning capital, those multiples feel attractive relative to many growth-for-growth-sake education names.

Technical context

The technical setup is supportive but not frothy: the 10/20/50-day moving averages cluster in the low-to-mid $34s, and the 9-day EMA is slightly above the 21-day average, suggesting constructive momentum. RSI sits at ~58, in neutral-to-favorable territory, and the MACD histogram indicates bullish momentum. Short interest has ticked higher recently to about 3.1M shares (settlement 03/13/2026), which can amplify moves but also means there is less crowded conviction on the long side.

Valuation framing

Market cap sits near $5.05B with enterprise value at roughly $4.95B. Given free cash flow of $263.1M, the company trades at an implicit FCF yield in the mid-single digits on current market value; combine that yield with an EV/EBITDA of 9.8 and a P/E under 19 and you have a business that is profitable, cash-generative and not heavily leveraged. For a company that just upsized guidance and runs a disciplined buyback program, paying a modest premium to the group is reasonable—the target of $45.00 implies a multiple re-rating toward what I would call a fairer valuation for a stable, cash-generative education platform while still leaving room for operational upside.

Catalysts (what can drive the stock higher)

• Enrollment beats and continued organic revenue growth: incremental improvement in enrollment in Mexico and Peru would validate management's guidance and revenue targets.
• Share repurchases: the $100M repurchase program announced 09/13/2024 and an additional $100M previously give a tangible pathway to EPS accretion if buybacks continue.
• Operational leverage from digital delivery: further mix shift to higher-margin digital programs will expand margins and convert revenue growth into free cash flow.
• Positive macro in Latin America and currency stability: improved consumer spending and stable FX would reduce translation losses and improve GAAP earnings comparables.

Trade plan (entry, stop, target and horizon)

Why 180 trading days? Education revenue and enrollment cycles are seasonally driven and management actions such as repurchases and margin improvements play out over multiple quarters. Giving the trade roughly half a year allows for these drivers to materialize without prematurely cutting a position on short-term volatility.

Position sizing and risk control

This is a medium-risk idea. Use a position size that limits potential loss to no more than 1-2% of portfolio capital if the stop is hit at $30.00. Consider trimming in tranches: sell 25-50% of the position at the mid-point to lock in gains, and hold the remainder toward the $45.00 target if fundamentals continue to improve.

Counterargument to the thesis

A valid counterargument is that Laureate's apparent momentum is cosmetic and driven by temporary enrollment rebounds or currency effects that won't sustain margin expansion. If revenue growth stalls or GAAP earnings continue to be hit heavily by FX translation losses, the stock could re-rate lower despite the buyback program. In that scenario, the P/E and EV/EBITDA multiples would be harder to justify and the market would demand deeper discounts.

Risks - what could go wrong (and what to watch)

• Macro and FX risk: Laureate's business is concentrated in Mexico and Peru; adverse currency moves or economic stress in those countries can hit revenue and GAAP earnings.
• Enrollment reversals: a weaker enrollment cycle or increased competition in the regions served would hit the top line and margin conversion assumptions.
• Execution risk on digital transition: the company needs to flex margins as it scales digital programs; if costs rise faster than expected, FCF could compress.
• Market multiple compression: even with good cash flow, broader investor rotation away from educational services or into higher-growth sectors could reduce the multiple applied to Laureate.
• Buyback reliance: capital returns are constructive, but if management leans too heavily on buybacks rather than investing for growth, long-term organic growth could slow.

What would change my mind

I would be less constructive if any of the following occur: company guidance is cut or materially revised downward; free cash flow falls significantly below the reported $263.1M; leverage rises meaningfully above the current debt-to-equity of ~0.11; or enrollment trends in Mexico/Peru roll over. Conversely, sustained revenue beats, accelerated buybacks and improved margins would make me more aggressive and could justify a higher target.

Conclusion

Laureate is not a moonshot growth name, but it is a sensible value play on education that is cash-generative, low-leverage and actively returning capital. That combination—plus recent guidance lifts and repurchase programs—gives a pragmatic path to upside. My trade is long at $35.38, stop at $30.00, target $45.00, over a long-term window of 180 trading days. If the company executes on enrollment and margin conversion while maintaining capital returns, the market should re-rate the shares higher.

Key signals to watch: quarterly enrollment figures, near-term guidance updates, quarterly free cash flow, and any material changes to the repurchase program.